Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07092436

Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device

The present investigation is configured as a multicenter clinical study in a within-group pilot phase.

This study aims to investigate primarily the feasibility of use and effectiveness of a treatment for upper limb function in children aged 4 to 18 years with congenital and acquired neuromotor disorders through a new portable robotic system, called PhiCube, designed for bilateral neuromotor rehabilitation of the upper limbs in subjects with neuromotor disorders.

In order to specifically investigate also the potential impact of PhiCube on movement planning aspects, the study will also involve a small group of children aged 4 to 18 years with Developmental Coordination Disorder (DCD).

Before (PreT0 and T0) and after (T1 and T2) treatment, standardized assessment tests will be administered. Regarding the investigation objectives reported above, the primary outcome measure will be the Melbourne Assessment-2 (MA2), a standardized, valid and reliable instrument for evaluating the quality of upper limb movement in children with neurological deficits, capable of measuring four elements of movement quality: range of motion, accuracy, dexterity and fluency. As secondary outcome measures, Abilhand-Kids has been chosen, a brief questionnaire that measures 21 main daily bimanual activities completed by the parent or caregiver, and various subtests and questionnaires aimed at evaluating the neuropsychological processes involved and the effects related to auditory feedback perception.

The treatment will have a total duration of approximately 3 months and will be organized in 3 weekly sessions lasting 45 minutes each, to reach a total of 30.

Descriptive statistics of the clinical and technological variables obtained in the evaluation and rehabilitation phases will be calculated. Subsequently, treatment efficacy analyses through the robotic device are planned, comparing pre-post clinical variables. All collected data will finally be analyzed in order to compare the rehabilitative efficacy of the device with respect to the different groups of participants identified based on diagnostic profile.

Recruiting

Interested in participating?

Request Info

Key information

Age range

4 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

IRCCS Eugenio Medea, Bosisio Parini, LC, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • For subjects with congenital and acquired neuromotor disorders:
  • Diagnosis of congenital and acquired neuromotor disorders
  • Age between 4 and 18 years at the time of recruitment
  • Modified Ashworth Scale (MAS) less than 3
  • MACS level I-IV
  • Sufficient capacity to understand the proposed activities
  • Availability to attend the facility
  • For subjects with developmental coordination disorder (DCD):
  • Diagnosis of developmental coordination disorder (DCD)
  • Age between 4 and 18 years at the time of recruitment
  • Sufficient capacity to understand the proposed activities
  • Availability to attend the facility

Exclusion criteria

  • For subjects with congenital and acquired neuromotor disorders:
  • Severe sensory deficits
  • Onset of pathologies that prevent participation
  • Worsening of pre-existing comorbidities
  • For subjects with developmental coordination disorder (DCD):
  • Severe sensory deficits
  • Onset of pathologies that prevent participation
  • Worsening of pre-existing comorbidities

Treatment and study plan

Robotic bilateral upper limb rehabilitation training

Device

Bilateral upper limb rehabilitation using PhiCube, a modular robotic end-effector device with two motorized axes that can assist or resist patient movements. Treatment consists of 30 sessions over 3 months (3 sessions/week, 45 minutes each) combining motor training with gaming elements specifically designed for pediatric populations. The device's modular design allows customization for individual patient needs and bilateral coordination training. Sessions focus on improving range of motion, precision, dexterity, and movement fluidity through controlled, repetitive, high-intensity exercises in children aged 4-18 years with neuromotor disorders and developmental coordination disorder.

Primary outcomes

  1. Upper limb movement quality in children with neurological deficits

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    Quality of upper limb movement in children with neurological deficits, measured through Melbourne Assessment-2 (MA2), which is able to measure four elements of movement quality: range of motion, precision, dexterity and fluidity.

Secondary outcomes

  1. ABILHAND-Kids Questionnaire

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    A brief questionnaire measuring 21 main bimanual daily activities. Scores are assigned by parents based on the child's difficulty in performing daily activities, with a 3-point scale (impossible, difficult, easy).

  2. Leiter-3 Sustained Attention Subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    A subtest of the Leiter-3 non-verbal cognitive scale that evaluates sustained visual attention through tasks of increasing complexity within a specific time period. The number of correctly selected target elements is recorded.

  3. NEPSY-II Inhibition Subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    Evaluates inhibitory control abilities of automatic verbal responses through administration of 3 different conditions for two different stimulus sets, requiring naming, inhibition with reversal, and alternating responses based on color.

  4. NEPSY-II Auditory Attention Subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    Assesses the ability to maintain sustained attention to auditory stimuli performance and inhibit automatic motor responses in two tasks of increasing complexity with incremental executive control demands.

  5. NEPSY-II Manual Posture Imitation subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    This subtest assesses the child's ability to accurately imitate a series of progressively complex hand and finger postures demonstrated by the examiner. The raw score is obtained by summing the number of correctly executed postures, separately recorded for the dominant and non-dominant hands. From the total raw score, a weighted score is derived, which in turn is used to calculate the standard score based on normative data.

  6. NEPSY-II Manual Motor Sequences subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    This subtest evaluates the child's ability to observe and reproduce sequences of hand movements demonstrated by the examiner. The sequences become progressively more complex and require the integration of motor planning, attention, and imitation abilities. The raw score is calculated by summing the number of correctly imitated sequences. From the total raw score, a weighted score is derived, which is then converted into a standard score based on normative data.

  7. NEPSY-II Arrow subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    This subtests evaluates the ability to judge line orientation considering direction, distance, orientation, and angularity. The task requires the integration of visual attention, orientation discrimination, and mental rotation.

    The raw score is obtained by summing the number of correct responses across all items. From this total raw score, a weighted score is calculated and then converted into a standard score based on age-specific normative data.

  8. NEPSY-II Route Finding subtest

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    This subtest assesses the ability to use a small schematic map to locate targets on a larger schematic map.

    The raw score corresponds to the number of correctly identified routes. From this raw score, a weighted score is derived and then transformed into a standard score using normative tables based on the child's age.

  9. BRIEF P/2 Questionnaire

    Time frame: Assessed at 4 time points: - PreT0: 2 months before treatment initiation - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period - T2: 1 month after treatment completion

    Parent-administered questionnaire evaluating executive functions in daily life contexts. Parents rate behaviors on a 3-point Likert scale based on frequency over the past six months.

  10. Usability questionnaire

    Time frame: T1: Immediately after completing the treatment period

    Custom questionnaire administered to stakeholders (children and operators) at treatment completion to investigate system usability.

  11. Acceptability questionnaire

    Time frame: T1: Immediately after completing the treatment period

    Custom questionnaire administered to stakeholders (children and operators) at treatment completion to investigate system acceptability.

  12. Compliance questionnaire

    Time frame: T1: Immediately after completing the treatment period

    Custom questionnaire administered to stakeholders (children and operators) at treatment completion to investigate child and operator compliance.

  13. Movement smoothness

    Time frame: - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period

    Measures of how continuous and even a movement is, without sudden stops or changes in speed. It is measured by the normalized jerk.

  14. Trajectory error

    Time frame: - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period

    Measures the error made by one limb in following a proposed trajectory via the screen.

  15. Bilateral coordination

    Time frame: - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period

    Measures coordination between limbs in performing the same movement simultaneously by calculating the difference between axes coordinates.

  16. Audio Feedback Effect Evaluation

    Time frame: - T0: Immediately before starting PhiCube treatment - T1: Immediately after completing the treatment period

    Assessment of how audio feedback influences motivational and satisfaction aspects through three interaction conditions (no feedback, reward feedback, help feedback) using VAS scales for fun and engagement, adapted In-game Questionnaire, and open-ended questions about the child's experience.

Study contacts

Contact information is provided by the study sponsor or research team.

Matteo Malosio, PhD

CONTACT

[email protected]

+39.0341.235.0203

Sponsors and collaborators

Lead sponsor

Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato

Other

Collaborators

  • Fondazione Don Carlo Gnocchi ETS
  • IRCCS Eugenio Medea
  • IRCCS Fondazione Istituto Neurologico Mondino Pavia
  • IRCCS Fondazione Stella Maris
  • Ospedale IRCCS G. Gaslini di Genova

Registry information

Official study title

Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device.

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 29, 2025
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.